Accuronix Therapeutics

Business Data, Corporate Office and Headquarter Address

About

Accuronix Therapeutics is Biotechnology in United States that focus on developer business. Founded in 2015. They cover business area such as developer, novel therapy, cancer therapy, technology, cancer cell, doctor, efficacy, toxicity risk.

Business Type

Biotechnology

Country

United States

Founded

2015
( 9 years old in 2024 )

Company Focus

Developer

Website

-

Corporate Office and Headquarter Office address:

4340 Duncan Avenue
Suite 210
Saint Louis, MO 63110
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developernovel therapycancer therapytechnologycancer celldoctorefficacytoxicity risk

* We use standard office opening hours in near Accuronix Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Accuronix Therapeutics Frequently Asked Questions

What or who is Accuronix Therapeutics?

Accuronix Therapeutics is Biotechnology business from United States that founded in 2015 (9 years old in 2024), Accuronix Therapeutics business is focusing on Developer.

Where is Accuronix Therapeutics headquarter and corporate office address?

Accuronix Therapeutics headquarter office and corporate office address is located in 4340 Duncan Avenue Suite 210 Saint Louis, MO 63110 United States.

Where is Accuronix Therapeutics country origins?

Accuronix Therapeutics was founded in United States.

What is Developer business focus on?

In 2024, Accuronix Therapeutics is currently focus on developer sector.

Developer Business Interest from Google Trend

Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Accuronix Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.